scholarly journals An Unusual Case of Enteropathy-associated T-cell Lymphoma Type 2 with Pulmonary Metastasis

Cureus ◽  
2019 ◽  
Author(s):  
Vineel Bhatlapenumarthi ◽  
Anannya Patwari ◽  
Ahmad D Siddiqui
2015 ◽  
Vol 22 (2) ◽  
pp. 242-247 ◽  
Author(s):  
Nicole M. Grigg-Gutierrez ◽  
Rodolfo Estremera-Marcial ◽  
William W. Cáceres ◽  
Doris H. Toro

1996 ◽  
Vol 23 (5-6) ◽  
pp. 631-634 ◽  
Author(s):  
August Zabernigg ◽  
Falko Fend ◽  
Josef Thaler ◽  
Claus Gattringer

Cancers ◽  
2021 ◽  
Vol 13 (20) ◽  
pp. 5238
Author(s):  
Matthias Kieslinger ◽  
Alexander Swoboda ◽  
Nina Kramer ◽  
Patricia Freund ◽  
Barbara Pratscher ◽  
...  

Alimentary lymphomas arising from T cells are rare and aggressive malignancies in humans. In comparison, they represent the most common anatomical form of lymphoma in cats. Due to the low prevalence in humans, the underlying pathomechanism for these diseases is poorly characterised, limiting experimental analysis and therapeutic exploration. To date, activating mutations of the JAK/STAT core cancer pathway and particularly the STAT5B oncoprotein have been identified in human enteropathy-associated T cell lymphoma. Here, we describe a high homology of human and feline STAT3 and STAT5B proteins and strong conservation at the genomic level. Analysis of 42 samples of feline T cell alimentary lymphoma reveals broad activation of STAT3 and STAT5B. Screening for known activating mutations in STAT3 or STAT5B identifies the presence of the STAT5BN642H driver mutation in feline enteropathy-associated T cell lymphoma in 7 out of 42 (16.67%) samples in total. Regarding lymphoma subtypes, the majority of mutations with 5 out of 17 (29.41%) cases were found in feline enteropathy-associated lymphoma type II (EATL II). This identification of an oncogenic STAT5B driver mutation in felines recapitulates the genetic situation in the corresponding human disease, thereby establishing the cat as a potential new model for a rare and incurable human T cell disease.


Cureus ◽  
2020 ◽  
Author(s):  
Tejaswi Kanderi ◽  
Siddharth Goel ◽  
Isha Shrimanker ◽  
Vinod K Nookala ◽  
Pratiksha Singh

Pathology ◽  
2018 ◽  
Vol 50 ◽  
pp. S70-S71
Author(s):  
Leana Downs ◽  
Connull Leslie ◽  
Jeremy Parry ◽  
Sheng Khor

CHEST Journal ◽  
2019 ◽  
Vol 156 (4) ◽  
pp. A587
Author(s):  
Christine Nguyen ◽  
John Kileci ◽  
Paru Patrawalla ◽  
Lina Miyakawa

2004 ◽  
Vol 45 (2) ◽  
pp. 114-118 ◽  
Author(s):  
Jillian Wells ◽  
Christopher A Kosky ◽  
Richard A Scolyer ◽  
Stephen Lee ◽  
Peter TP Bye ◽  
...  

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 1374-1374
Author(s):  
Ida Munster-Ikonomou ◽  
Anne Tierens ◽  
Gunhild Troen ◽  
Hege Aamodt ◽  
Sverre Heim ◽  
...  

Abstract We studied six cases of a novel type of nodal peripheral T-cell lymphoma. Three cases with this disease were recently described by de Leval et al. (de Leval L, Savilo E, Longtine J, et al. Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype. Am J Surg Pathol2001;25:395–400). The entity was named peripheral T-cell lymphoma with follicular involvement because of its distinctive histological features. We report an additional six well-characterized cases and describe the molecular and cytogenetic findings. The neoplastic T-cells of this lymphoma type express CD4 and Bcl-6, and home to the B-lymphoid follicles. This suggests an origin of the lymphoma from an as yet poorly characterized subset of Bcl-6 expressing intra-follicular T-helper cells. Of interest, the cytogenetic data and/or the study of T-cell receptor gamma gene rearrangements revealed more than one clone in each case. Cytogenetics further revealed complex karyotypes without recurrent chromosomal aberrations. We also studied the presence of somatic mutations in the 5′ untranslated region of the BCL-6 gene in four of the cases but no somatic hypermutation was detected. Clinically, the cases presented with widespread lymph node involvement at diagnosis and multiple relapses occurred after treatment. All patients received a CHOP-based chemotherapy regimen, later followed by high dose chemotherapy with stem cell rescue in five patients. One patient died with lymphoma and hemophagocytic syndrome 24 months after diagnosis, one patient is alive with disease after 27 months from diagnosis, whereas the other four patients are in complete remission 12 to 124 months after diagnosis. In conclusion, we confirm that peripheral T-cell lymphoma with follicular involvement is a distinct lymphoma type and we show that the lymphoma is oligo-clonal. The clinical findings are those of an intermediately aggressive lymphoma type. Although minimal lymph node infiltration with lymphoma cells at diagnosis and oligo-clonality is also characteristic of angio-immunoblastic T-cell lymphoma, we believe that peripheral T-cell lymphoma with follicular involvement is a distinct T-cell lymphoma type. In contrast to angio-immunoblastic T-cell lymphoma it is characterized by the typical infiltration of lymphoma cells in B-lymphoid follicles, coagulation necrosis, the absence of proliferation of high endothelial venules and follicular dendritic cells in T-cell areas, as well as the absence of EBV infection. It is likely that T-cell lymphoma with follicular involvement arises from Bcl-6+ intra-follicular T-cells. No recurrent genetic defects have been identified but the oligo-clonal nature of the lymphoma is intriguing. The latter suggests that the triggering oncogenic factors are external, such as infection.


Sign in / Sign up

Export Citation Format

Share Document